Literature DB >> 2120848

Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains.

B A Castro1, S W Barnett, L A Evans, J Moreau, K Odehouri, J A Levy.   

Abstract

Seven HIV-2 isolates recovered from peripheral blood mononuclear cells (PBMC) of patients from the Ivory Coast have been biologically characterized. All seven strains replicated well in primary human lymphocyte and macrophage cultures and in established human T cell lines. They showed differences in infectivity and replicating ability in primary PBMC cultures from chimpanzees, rhesus macaques, and baboons. Moreover, variations in levels of virus replication in PBMC from 13 seronegative donors were observed. Four strains (UC2, UC3, UC7, and UC8) were highly cytopathic and caused extensive surface CD4 antigen depletion in acutely infected PBMC and SupT1 cells. Two strains (UC1 and UC6) showed minimal or no cytopathology, no CD4 down-modulation, and much lower levels of virus protein expression in SupT1 cells. These findings reflect the heterogeneity of HIV-2 strains and suggest that these biological properties could influence pathogenesis in the host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120848     DOI: 10.1016/0042-6822(90)90350-z

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.

Authors:  Miranda Harris; Sneha Ratnapriya; Angela Chov; Héctor Cervera; Alisha Block; Christopher Gu; Nathaniel Talledge; Louis M Mansky; Joseph Sodroski; Alon Herschhorn
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

2.  Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.

Authors:  Christopher P Locher; Stephanie A Witt; Brian G Herndier; Nancy W Abbey; Klara Tenner-Racz; Paul Racz; Nancy B Kiviat; Krishna K Murthy; Kathleen Brasky; Michelle Leland; Jay A Levy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Authors:  B Schramm; M L Penn; E H Palacios; R M Grant; F Kirchhoff; M A Goldsmith
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.

Authors:  Haihan Song; Emi E Nakayama; Masaru Yokoyama; Hironori Sato; Jay A Levy; Tatsuo Shioda
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

5.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.

Authors:  Ken Kono; Haihan Song; Masaru Yokoyama; Hironori Sato; Tatsuo Shioda; Emi E Nakayama
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.

Authors:  M Le Guern; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain.

Authors:  S W Barnett; M Quiroga; A Werner; D Dina; J A Levy
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  The nef gene of simian immunodeficiency virus SIVmac1A11.

Authors:  R E Unger; M L Marthas; E Pratt-Lowe; P A Padrid; P A Luciw
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.